Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Локализация ACE2 в организме: по следам замочной скважины SARS-CoV-2
2020-12-03
SCID: 54.1/qxh92xsd
Discuss with AI
ACE2 body distributionACE2-expressing organsCOVID-19 disease progressionSARS-CoV-2 host-cell entrymultiple organ failure
Figures from the paper
Abstract (AI)
The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV-2 must bind the ACE2 for entering the host cells in humans, its expression and body localization are critical to track the potential target organ of this infection and to outline disease progression and clinical outcomes. Here, we mapped the physiological body distribution, expression, and activities of ACE2 and discussed its potential correlations and mutal interactions with the disparate symptoms present in SARS-CoV-2 patients at the level of different organs. We highlighted that despite during SARS-CoV-2 infection ACE2-expressing organs may become direct targets, leading to severe pathological manifestations, and subsequent multiple organ failures, the exact mechanism and the potential interactions through which ACE2 acts in these organs is still heavily debated. Further scientific efforts, also considering a personalized approach aimed to consider specific patient differences in the mutual interactions ACE2-SARS-CoV-2 and the long-term health effects associated with COVID-19 are currently mandatory.
Key Findings
1
ACE2 expression and physiological distribution across organs are critical for identifying potential SARS-CoV-2 target tissues and understanding disease progression.
2
ACE2-expressing organs may serve as direct viral targets, contributing to severe pathological manifestations and subsequent multiple-organ failure.
3
Further research should address patient-specific ACE2–SARS-CoV-2 interactions and their long-term health consequences using personalized approaches.
4
The mechanisms by which ACE2 mediates organ-specific effects during SARS-CoV-2 infection remain heavily debated and incompletely understood.
5
The paper maps ACE2 localization, expression, and activity and relates them to organ-specific symptoms observed in SARS-CoV-2 patients.
Research Object
ACE2 expression and physiological body distribution across human organs
Research Subject
The relationships between ACE2 localization, activity, and SARS-CoV-2 infection manifestations, including target-organ involvement and disease progression
Publication Details
Publication Date
2020-12-03
Journal
Publisher
ISSN
Cited by
304
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai11
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis2004
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study2020
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients2020
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China2020
Guillain–Barré Syndrome Associated with SARS-CoV-22020
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia2020
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction2020
Miller Fisher syndrome and polyneuritis cranialis in COVID-192020
Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology2020
Considerations for Postacute Rehabilitation for Survivors of COVID-192020